| Breakdown | TTM | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 161.70M | 152.20M | 128.20M | 104.00M | 95.16M | 78.99M |
| Gross Profit | 85.40M | 76.10M | 58.60M | 39.70M | 36.36M | 32.41M |
| EBITDA | 36.10M | 35.60M | 33.50M | 18.60M | 17.74M | 18.39M |
| Net Income | 22.90M | 22.50M | 22.00M | 12.70M | 11.90M | 13.61M |
Balance Sheet | ||||||
| Total Assets | 163.90M | 157.90M | 130.30M | 108.90M | 93.47M | 83.84M |
| Cash, Cash Equivalents and Short-Term Investments | 22.30M | 40.70M | 32.90M | 27.70M | 24.92M | 24.38M |
| Total Debt | 19.80M | 15.10M | 11.30M | 11.30M | 13.08M | 11.64M |
| Total Liabilities | 61.10M | 63.10M | 52.40M | 45.80M | 48.95M | 51.85M |
| Stockholders Equity | 102.80M | 94.80M | 77.90M | 63.10M | 44.52M | 31.99M |
Cash Flow | ||||||
| Free Cash Flow | 25.50M | 29.30M | 24.70M | 10.10M | 16.46M | 9.42M |
| Operating Cash Flow | 27.30M | 30.50M | 25.60M | 10.70M | 17.86M | 10.54M |
| Investing Cash Flow | -9.20M | -11.70M | -5.10M | -2.20M | -5.78M | -13.32M |
| Financing Cash Flow | -18.00M | -11.00M | -15.30M | -5.70M | -11.54M | 5.86M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £273.48M | 6.69 | 23.18% | 3.80% | 9.93% | -15.65% | |
68 Neutral | £10.44B | 3.32 | 12.75% | 6.78% | -2.34% | 2.55% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
60 Neutral | £32.75M | 13.98 | 3.68% | 7.96% | -9.55% | ― | |
58 Neutral | £124.83M | 3.75 | 4.98% | ― | 15.42% | ― | |
48 Neutral | £8.73M | -0.20 | ― | ― | ― | ― | |
46 Neutral | £597.88M | -2.93 | -9.28% | ― | -15.79% | -211.91% |